Trident Pharmaceuticals Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Trident Pharmaceuticals General Information

Description

Developer of novel immunomodulatory drug products. The company develops therapies for autoimmune diseases and allergic diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 184 High Street
  • Boston, MA 02110
  • United States
+1 (857)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 184 High Street
  • Boston, MA 02110
  • United States
+1 (857)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trident Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Nov-2015 Completed Out of Business
3. Later Stage VC 21-May-2014 Completed Generating Revenue
2. Later Stage VC 01-Sep-2012 Completed Generating Revenue
1. Early Stage VC 01-Mar-2006 Completed Startup
To view Trident Pharmaceuticals’s complete valuation and funding history, request access »

Trident Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel immunomodulatory drug products. The company develops therapies for autoimmune diseases and allergic d
Biotechnology
Boston, MA

Plymouth Meeting, PA
 

Gaithersburg, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Trident Pharmaceuticals Competitors (40)

One of Trident Pharmaceuticals’s 40 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Altimmune Corporate Backed or Acquired Gaithersburg, MD
NexImmune Formerly VC-backed Gaithersburg, MD
Anokion Venture Capital-Backed Ecublens, Switzerland
Hansa Biopharma Corporation Lund, Sweden
You’re viewing 5 of 40 competitors. Get the full list »

Trident Pharmaceuticals Patents

Trident Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2003261492-A1 Vaccine Active 08-May-1998
AU-2003261492-B2 Vaccine Inactive 08-May-1998
US-7914791-B1 Vaccine Inactive 08-May-1998
EP-1075274-A2 Immunomodulators for vaccines Inactive 08-May-1998
CA-2331832-A1 E.coli heat-labile enterotoxin subunit b (etxb) as an immunomodulator Inactive 08-May-1998 A61K39/245
To view Trident Pharmaceuticals’s complete patent history, request access »

Trident Pharmaceuticals FAQs

  • When was Trident Pharmaceuticals founded?

    Trident Pharmaceuticals was founded in 2006.

  • Where is Trident Pharmaceuticals headquartered?

    Trident Pharmaceuticals is headquartered in Boston, MA.

  • What industry is Trident Pharmaceuticals in?

    Trident Pharmaceuticals’s primary industry is Biotechnology.

  • Is Trident Pharmaceuticals a private or public company?

    Trident Pharmaceuticals is a Private company.

  • What is Trident Pharmaceuticals’s current revenue?

    The current revenue for Trident Pharmaceuticals is .

  • How much funding has Trident Pharmaceuticals raised over time?

    Trident Pharmaceuticals has raised $275K.

  • Who are Trident Pharmaceuticals’s competitors?

    Inovio Pharmaceuticals, Altimmune, NexImmune, Anokion, and Hansa Biopharma are some of the 40 competitors of Trident Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »